Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 2/20 | 0.39 |
| ▸ | ALPI | P09923 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | XIAP | P98170 | 1/20 | 0.39 |
| ▸ | GRIA2 | P42262 | 5/20 | 0.37 |
| ▸ | GRIA1 | P42261 | 4/20 | 0.37 |
| ▸ | GRIA3 | P42263 | 4/20 | 0.37 |
| ▸ | GRIA4 | P48058 | 4/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | BLM | P54132 | 2/20 | 0.36 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Histidine SCHEMBL874923 | 1.00 | SLC7A5 (0.43) | SLC7A5CYP3A4CYP1A2PKMALPI | |
| Histidine SCHEMBL7521151 | 0.94 | SLC7A5 (0.39) | SLC7A5CYP3A4CYP1A2PKMALPI | |
| Histidine SCHEMBL22769647 | 0.94 | SLC7A5 (0.39) | SLC7A5CYP3A4CYP1A2PKMALPI | |
| Histidine SCHEMBL3967555 | 0.94 | SLC7A5 (0.39) | SLC7A5CYP3A4CYP1A2PKMALPI | |
| Histidine SCHEMBL163442 | 0.94 | SLC7A5 (0.47) | SLC7A5CYP3A4CYP1A2PKMALPI | |
| Histidine SCHEMBL995910 | 0.94 | SLC7A5 (0.47) | SLC7A5CYP3A4CYP1A2PKMALPI | |
| Histidine SCHEMBL8080341 | 0.94 | SLC7A5 (0.47) | SLC7A5CYP3A4CYP1A2PKMALPI | |
| Histidine SCHEMBL3259 | 0.94 | SLC7A5 (0.47) | SLC7A5CYP3A4CYP1A2PKMALPI | |
| Histidine SCHEMBL163443 | 0.94 | SLC7A5 (0.47) | SLC7A5CYP3A4CYP1A2PKMALPI | |
| Histidine SCHEMBL388563 | 0.94 | SLC7A5 (0.47) | SLC7A5CYP3A4CYP1A2PKMALPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1794323-B1 | IN VIVO INCORPORATION OF ALKYNYL AMINO ACIDS INTO PROTEINS IN EUBACTERIA | SCRIPPS RESEARCH INST (US) | 2014-08-06 | — | — | EP | claimed |
| US-20240197882-A1 | HUMANIZED ANTI-SIALYL-TN GLYCAN ANTIBODIES AND USES THEREOF | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2024-06-20 | — | — | US | disclosed |
| EP-4326777-A1 | HUMANIZED ANTI-SIALYL-TN GLYCAN ANTIBODIES AND USES THEREOF | Ramot at Tel-Aviv University Ltd. (IL) | 2024-02-28 | — | — | EP | disclosed |
| US-20240043561-A1 | HUMANIZED ANTIBODIES AND FRAGMENTS THEREOF BINDING TO CARBOHYDRATE ANTIGENS AND USES THEREOF | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2024-02-08 | — | — | US | disclosed |
| EP-4251653-A1 | HUMANIZED ANTIBODIES AND FRAGMENTS THEREOF BINDING TO CARBOHYDRATE ANTIGENS AND USES THEREOF | Ramot at Tel-Aviv University Ltd. (IL) | 2023-10-04 | — | — | EP | disclosed |
| US-20230174664-A1 | ANTIBODIES TO CARBOHYDRATE ANTIGENS | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2023-06-08 | — | — | US | disclosed |
| US-20230058044-A1 | CHIMERIC ANTIGEN RECEPTOR TO CARBOHYDRATE ANTIGENS | UNIV RAMOT (IL) | 2023-02-23 | — | — | US | disclosed |
| CN-115702892-A | Application of serine in preparation of medicine for preventing and/or treating acute pancreatitis | 四川大学华西医院 | 2023-02-17 | — | — | CN | disclosed |
| EP-4065605-A1 | ANTIBODIES TO CARBOHYDRATE ANTIGENS | Ramot at Tel-Aviv University Ltd. (IL) | 2022-10-05 | — | — | EP | disclosed |
| WO-2022113066-A1 | HUMANIZED ANTIBODIES AND FRAGMENTS THEREOF BINDING TO CARBOHYDRATE ANTIGENS AND USES THEREOF | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2022-06-02 | — | — | WO | disclosed |
| US-9783783-B2 | Compositions and methods for the expansion of stem cells | CORNELL UNIVERSITY (US) | 2017-10-10 | — | — | US | disclosed |
| US-9321847-B2 | Activatable toxin complexes comprising a cleavable inhibitory peptide | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2016-04-26 | — | — | US | disclosed |
| US-20150368613-A1 | COMPOSITIONS AND METHODS FOR THE EXPANSION OF STEM CELLS | CORNELL UNIVERSITY | 2015-12-24 | — | — | US | disclosed |
| WO-2014120714-A1 | COMPOSITIONS AND METHODS FOR THE EXPANSION OF STEM CELLS | CORNELL UNIVERSITY (US) | 2014-08-07 | — | — | WO | disclosed |
| EP-1794323-B1 | IN VIVO INCORPORATION OF ALKYNYL AMINO ACIDS INTO PROTEINS IN EUBACTERIA | SCRIPPS RESEARCH INST (US) | 2014-08-06 | — | — | EP | disclosed |
| US-20130202598-A1 | ACTIVATABLE TOXIN COMPLEXES COMPRISING A CLEAVABLE INHIBITORY PEPTIDE | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2013-08-08 | — | — | US | disclosed |
| WO-2012038950-A1 | ACTIVATABLE TOXIN COMPLEXES COMPRISING A CLEAVABLE INHIBITORY PEPTIDE | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2012-03-29 | — | — | WO | disclosed |
| WO-2002006455-A2 | REGULATION OF HUMAN AIRWAY TRYPSIN PROTEASE-LIKE ENZYME | BAYER AKTIENGESELLSCHAFT (DE) | 2002-01-24 | — | — | WO | disclosed |
| EP-1025241-A2 | MULTIPLY-SUBSTITUTED PROTEASE VARIANTS | GENENCOR INTERNATIONAL INC. (US) | 2000-08-09 | — | — | EP | disclosed |
| WO-1999020770-A2 | MULTIPLY-SUBSTITUTED PROTEASE VARIANTS | GENENCOR INTERNATIONAL, INC. (US) | 1999-04-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240043561-A1 | HUMANIZED ANTIBODIES AND FRAGMENTS THEREOF BINDING TO CARBOHYDRATE ANTIGENS AND USES THEREOF | CD47, FCGR2A, FCGR3B | SLC7A5 2932/4885CYP3A4 4394/4885CYP1A2 4810/4885 |
| US-20230174664-A1 | ANTIBODIES TO CARBOHYDRATE ANTIGENS | SSB, FCGR3B, FCGR2A | SLC7A5 2049/4885CYP3A4 4872/4885CYP1A2 4870/4885 |
| US-20230058044-A1 | CHIMERIC ANTIGEN RECEPTOR TO CARBOHYDRATE ANTIGENS | CD47, FCGR2A, CD2 | SLC7A5 2263/4885CYP3A4 4632/4885CYP1A2 4757/4885 |
| US-20240197882-A1 | HUMANIZED ANTI-SIALYL-TN GLYCAN ANTIBODIES AND USES THEREOF | FUT5, SIGLEC7, CD44 | SLC7A5 1097/4885CYP3A4 2740/4885CYP1A2 4607/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.